GreenSignal Bio Pharma fixes price band of Rs 76-80 for IPO
The company plans to raise Rs 112 crore
Vaccine manufacturing firm GreenSignal Bio Pharma has fixed the price band at Rs 76-80…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Vyome Biosciences administers first in-human dose of VB 1953 in US
The Phase 1 clinical study was conducted in patients with facial acne
Ajanta Pharma launches BP lowering tablets in US
The company’s product is a generic version of Daiichi Sankyo's Azor tablets
Strides Shasun receives US FDA approval for Abacavir Tablets
Abacavir Tablets is indicated for the treatment of HIV-1 infection
Novartis wins two Prix Galien Foundation Awards
Gleevec recognised as 'Discovery of the Decade' for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product
Advanced Enzyme Technologies in agreement with JC Biotech
To acquire a 70 per cent stake for a consideration of Rs 50 crores
Strides Shasun announces Q2 FY17 results
Revenues has been posted at Rs 9,461 million, showing a growth of 33 per cent Y-o-Y
Sun Pharma to acquire Ocular Technologies
Announces US launch of authorised generics for Benicar, Benicar HCT, Azor and Tribenzor
Teva Pharmaceuticals in partnership with IBM
To enable drug development and chronic disease management with Watson
DRL in pact with Gland Pharma in the US market
To market and distribute a diverse portfolio of eight injectable ANDAs